Related references
Note: Only part of the references are listed.IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. Mace et al.
GUT (2018)
Immunological effects of a novel RNA-based adjuvant in liver cancer patients
Luisa Circelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Cheng Sun et al.
ONCOIMMUNOLOGY (2017)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
Kai-chao Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Emerging molecular therapeutic targets for cholangiocarcinoma
Sumera Rizvi et al.
JOURNAL OF HEPATOLOGY (2017)
Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge
Ali Naboush et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
Masatoshi Kudo
ONCOLOGY (2017)
CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
Fei Peng et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for Tand N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen et al.
ANNALS OF SURGERY (2017)
Markers and Function of Human NK Cells in Normal and Pathological Conditions
Genny Del Zotto et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
CD147 is increased in HCC cells under starvation and reduces cell death through upregulating p-mTOR in vitro
Xingchun Gou et al.
APOPTOSIS (2016)
PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma
Francesco Sabbatino et al.
CLINICAL CANCER RESEARCH (2016)
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
Qiong J. Wang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response
Paola Cappello et al.
ONCOIMMUNOLOGY (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Cytokines in cancer drug resistance: Cues to new therapeutic strategies
Valerie Sloane Jones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
Brigitta Omazic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Tobias Eggert et al.
CANCER CELL (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma
Benita Wolf et al.
CANCER RESEARCH (2016)
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
Engin Guerlevik et al.
GASTROENTEROLOGY (2016)
Tumor-Derived Exosomes Elicit Tumor Suppression in Murine Hepatocellular Carcinoma Models and Humans In Vitro
Quan Rao et al.
HEPATOLOGY (2016)
Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma
Mohamed M. Abdelrahman et al.
HUMAN IMMUNOLOGY (2016)
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers
Andrew L. Coveler et al.
INVESTIGATIONAL NEW DRUGS (2016)
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Davendra P. S. Sohal et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Edward P. Balaban et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
Markus W. Loeffler et al.
JOURNAL OF HEPATOLOGY (2016)
Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma
Abdelfattah M. Attallah et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2016)
Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
Qingda Meng et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM
Seulki Cho et al.
MABS (2016)
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang et al.
NATURE MEDICINE (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Pancreatic Cancer Epidemiology, Detection, and Management
Qiubo Zhang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma
Vanaja Konduri et al.
ONCOIMMUNOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
Todd Crocenzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
Tsuneo Ikenoue et al.
SCIENTIFIC REPORTS (2016)
Hepatocellular carcinoma: Review of disease and tumor biomarkers
Jin Un Kim et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer
Lihong Zhang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
Patrick R. Hagner et al.
BLOOD (2015)
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes et al.
CANCER CELL (2015)
B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
Fu-biao Kang et al.
CANCER CELL INTERNATIONAL (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes-Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The yin and yang of evasion and immune activation in HCC
Oxana V. Makarova-Rusher et al.
JOURNAL OF HEPATOLOGY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Pia Edenvik et al.
LIVER INTERNATIONAL (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
Shintaro Tsukinaga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management
Kelly J. Lafaro et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells
Xin Wan et al.
ONCOTARGET (2015)
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
Kevin C. Soares et al.
ONCOTARGET (2015)
A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
Aurelie Collignon et al.
ONCOTARGET (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Kevin C. Soares et al.
JOURNAL OF IMMUNOTHERAPY (2014)
A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis
Su Jin Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts
Z-Y Chen et al.
BRITISH JOURNAL OF CANCER (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
Hans-Heinrich Oberg et al.
CANCER RESEARCH (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
Fares Al-Ejeh et al.
CLINICAL CANCER RESEARCH (2014)
Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
Shigeo Koido et al.
CLINICAL CANCER RESEARCH (2014)
Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma
Seo Young Park et al.
EUROPEAN JOURNAL OF CANCER (2014)
Epitope-Optimized Alpha-Fetoprotein Genetic Vaccines Prevent Carcinogen-Induced Murine Autochthonous Hepatocellular Carcinoma
Yuan Hong et al.
HEPATOLOGY (2014)
hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
Wen Jiang et al.
IMMUNOBIOLOGY (2014)
CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
Qichao Huang et al.
JOURNAL OF HEPATOLOGY (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
Qiangjun Sui et al.
JOURNAL OF IMMUNOLOGY (2014)
MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas
Haihong Zhong et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Producing IL15 Eradicate Established Pancreatic Tumor in Syngeneic Mice
Wei Jing et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Hepatocellular Carcinoma and Other Liver Lesions
Reena Salgia et al.
MEDICAL CLINICS OF NORTH AMERICA (2014)
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
W. Leconet et al.
ONCOGENE (2014)
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response
Chaitanya Ramesh Ekkirala et al.
PANCREAS (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Andrew E. Becker et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report
Hui Fan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Monica Enguita-German et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models
Xiao-Dong Zhu et al.
ANGIOGENESIS (2013)
A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
Michael A. Morse et al.
ANNALS OF SURGERY (2013)
Anti-tumor Efficacy of a Hepatocellular Carcinoma Vaccine Based on Dendritic Cells Combined with Tumor-derived Autophagosomes in Murine Models
Shu Su et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer
Stephanie K. Bunt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
Reena Shakya et al.
CANCER RESEARCH (2013)
Hepatocellular Carcinoma from an Immunologic Perspective
Tim F. Greten et al.
CLINICAL CANCER RESEARCH (2013)
Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer
Paola Cappello et al.
GASTROENTEROLOGY (2013)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Adjuvant Gemcitabine Therapy Improves Survival in a Locally Induced, R0-Resectable Model of Metastatic Intrahepatic Cholangiocarcinoma
Engin Guerlevik et al.
HEPATOLOGY (2013)
Natural killer cells in liver disease
Zhigang Tian et al.
HEPATOLOGY (2013)
High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
Rui Liao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
Masanori Kobayashi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Upregulation of Trop-2 quantitatively stimulates human cancer growth
M. Trerotola et al.
ONCOGENE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A balance of interleukin-12 and-23 in cancer
Shin Foong Ngiow et al.
TRENDS IN IMMUNOLOGY (2013)
Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
Thomas Clozel et al.
CANCER DISCOVERY (2013)
Fractionated Radioimmunotherapy With 90Y-Clivatuzumab Tetraxetan and Low-Dose Gemcitabine Is Active in Advanced Pancreatic Cancer
Allyson J. Ocean et al.
CANCER (2012)
B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
Tai-Wei Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
Dung T. Le et al.
CLINICAL CANCER RESEARCH (2012)
Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma
Takehiro Noda et al.
HEPATOLOGY (2012)
CD133+liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
Kwan Ho Tang et al.
HEPATOLOGY (2012)
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Koichi Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
Valerie Chew et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet et al.
LUNG CANCER (2012)
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
Mallika Singh et al.
NATURE BIOTECHNOLOGY (2012)
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma
Y. Chen et al.
ONCOGENE (2012)
Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma
Liping Yu et al.
Journal of Cancer (2012)
Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development
Tetyana Yevsa et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays
Taotao Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Enhancement of NK cell antitumor responses using an oncolytic parvovirus
Rauf Bhat et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
Synne Weden et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma
Jin-Xue Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice
Jeannette Cany et al.
JOURNAL OF HEPATOLOGY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Identification of HLA-A*0201-and A*2402-Restricted Epitopes of Mucin 5AC Expressed in Advanced Pancreatic Cancer
Sadaaki Yamazoe et al.
PANCREAS (2011)
Engineered T cells for pancreatic cancer treatment
Usha L. Katari et al.
HPB (2011)
Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets
Tamara Severi et al.
ACTA PHARMACOLOGICA SINICA (2010)
Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease
S. Behboudi et al.
BRITISH JOURNAL OF CANCER (2010)
Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
Jian-Cong Sun et al.
CANCER BIOLOGY & THERAPY (2010)
Overexpression of Aspartyl-(Asparaginyl)-β-Hydroxylase in Hepatocellular Carcinoma Is Associated With Worse Surgical Outcome
Kui Wang et al.
HEPATOLOGY (2010)
Differential antitumor effect of interleukin-12 family cytokines on orthotopic hepatocellular carcinoma
Chia-Hui Lo et al.
JOURNAL OF GENE MEDICINE (2010)
Risk of HCC: Genetic heterogeneity and complex genetics
Tommaso A. Dragani
JOURNAL OF HEPATOLOGY (2010)
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
Victoria Tovar et al.
JOURNAL OF HEPATOLOGY (2010)
Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice
Hiroto Kayashima et al.
JOURNAL OF IMMUNOLOGY (2010)
Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
Tim F. Greten et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Alan P. Venook et al.
ONCOLOGIST (2010)
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary
Gerald J. Mizejewski
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
IFN-α-Induced Apoptosis in Hepatocellular Carcinoma Involves Promyelocytic Leukemia Protein and TRAIL Independently of p53
Kerstin Herzer et al.
CANCER RESEARCH (2009)
Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients
Luca Degrate et al.
LANGENBECKS ARCHIVES OF SURGERY (2009)
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
Peng Hu et al.
MOLECULAR IMMUNOLOGY (2009)
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies
Bruno Christian Koehler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2008)
Novel centrosome protein, TCC52, is a cancer-testis antigen
Sichen Li et al.
CANCER SCIENCE (2008)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
C. Porta et al.
ANNALS OF ONCOLOGY (2008)
Tumour vascularization: sprouting angiogenesis and beyond
Femke Hillen et al.
CANCER AND METASTASIS REVIEWS (2007)
Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
Lisa H. Butterfield et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
IMC-A12, a human IgG, monoclonal antibody to the insulin-like growth factor I receptor
Eric K. Rowinsky et al.
CLINICAL CANCER RESEARCH (2007)
A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma
Robert G. Maki et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients
Viktoria N. Evdokimova et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy
Lixin Ma et al.
JOURNAL OF HEPATOLOGY (2007)
Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy
Masahiro Ohira et al.
TRANSPLANTATION (2006)
Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI)
Jan Schmidt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
S. Nagaraj et al.
INTERNATIONAL IMMUNOLOGY (2006)
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250
Baudewijn W. Hendrickx et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2006)
Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo
R Lim et al.
HEPATOLOGY (2006)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas
LQ Luo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?
F Farinati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
TRICOM vector based cancer vaccines
CT Garnett et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers
T Okada et al.
CLINICAL CANCER RESEARCH (2006)
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses
AI Garbe et al.
CANCER RESEARCH (2006)
Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-Activated T cells and dendritic cells after surgery: Report of a case
Ryota Higuchi et al.
SURGERY TODAY (2006)
Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis
T Okada et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
L Pukac et al.
BRITISH JOURNAL OF CANCER (2005)
Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules
MA Morse et al.
CLINICAL CANCER RESEARCH (2005)
Animal models of tumor immunity, immunotherapy and cancer vaccines
S Ostrand-Rosenberg
CURRENT OPINION IN IMMUNOLOGY (2004)
Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions
K Tsuneyama et al.
PATHOLOGY INTERNATIONAL (2004)
IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat
M Nakaji et al.
CARCINOGENESIS (2004)
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
DG Brockstedt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
JS Lee et al.
HEPATOLOGY (2004)
Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft
V Donckier et al.
TRANSPLANT IMMUNOLOGY (2004)
Targeting cytotoxic T lymphocytes for cancer immunotherapy
J Maher et al.
BRITISH JOURNAL OF CANCER (2004)
IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice
N Harada et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma
T Utsunomiya et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans
G Söderdahl et al.
TRANSPLANTATION (2003)
Reduced intensity conditioning regimens -: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma
P Hentschke et al.
BONE MARROW TRANSPLANTATION (2003)
Natural killer cells and dendritic cells: Rendezvous in abused tissues
A Moretta
NATURE REVIEWS IMMUNOLOGY (2002)
Mini-transplantation strategy for solid tumors
Y Takaue
INTERNATIONAL JOURNAL OF HEMATOLOGY (2002)
Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin
EC Shin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver reiieneration in mice
P Hanke et al.
CANCER GENE THERAPY (2002)
Systemic administration of liposome-encapsulated OK-432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-gamma-producing hepatic lymphocytes
K Uehara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice
S Homma et al.
JOURNAL OF GASTROENTEROLOGY (2001)
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant:: Clinical and immunological responses in patients with pancreatic adenocarcinoma
MK Gjertsen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation
EM Jaffee et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human α-fetoprotein
WS Meng et al.
MOLECULAR IMMUNOLOGY (2000)
Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning
R Saeki et al.
JOURNAL OF HEPATOLOGY (2000)
The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2000)
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma
M Nagao et al.
HEPATOLOGY (2000)
Share Paper
